Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 15;13(12):2050-2063.
doi: 10.4251/wjgo.v13.i12.2050.

Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?

Affiliations
Review

Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?

Tudor Mocan et al. World J Gastrointest Oncol. .

Abstract

Hilar cholangiocarcinoma (hCCA) is a primary liver tumor associated with a dim prognosis. The role of preoperative and palliative biliary drainage has long been debated. The most common techniques are endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD); however, recently developed endoscopic ultrasound-assisted methods are gaining more atention. Selecting the best available method in any specific scenario is crucial, yet sometimes challenging. Thus, this review aimed to discuss the available techniques, indications, perks, pitfalls, and timing-related issues in the management of hCCA. In a preoperative setting, PTBD appears to have some advantages: low risk of postprocedural complications (namely cholangitis) and better priming for surgery. For palliative purposes, we propose ERCP/PTBD depending on the experience of the operators, but also on other factors: the level of bilirubin (if very high, rather PTBD), length of the stenosis and the presence of cholangitis (PTBD), ERCP failure, or altered biliary anatomy.

Keywords: Endoscopic biliary drainage; Endoscopic ultrasound biliary drainage; Hilar cholangiocarcinoma; Percutaneous biliary drainage; Surgical oncology.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors have nothing to disclose.

Figures

Figure 1
Figure 1
Management algorithm in hilar cholangiocarcinoma. 1In high-volume centers with expertise in EUS. 2In centers specialized in ERCP and little experience in PTBD. 3Depending on the experience and preference of the patient. ERCP: Endoscopic retrograde cholangio-pancreatography; EUS: Endoscopic ultrasound; PTBD: Percutaneous transhepatic biliary drainage.

References

    1. Patel N, Benipal B. Incidence of Cholangiocarcinoma in the USA from 2001 to 2015: A US Cancer Statistics Analysis of 50 States. Cureus. 2019;11:e3962. - PMC - PubMed
    1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125. - PubMed
    1. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54:173–184. - PMC - PubMed
    1. Chen XP, Lau WY, Huang ZY, Zhang ZW, Chen YF, Zhang WG, Qiu FZ. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167–1175. - PubMed
    1. Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B, Lopez-Häänninen E, Neuhaus P. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg. 2009;249:303–309. - PubMed